Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SQI in Can$7m private placement:

This article was originally published in Clinica

Executive Summary

Toronto, Ontario-based SQI Diagnostics has announced a private placement offering of up to Can$7m ($6.6m) of units of the company. Each unit will consist of one share and one half of a share purchase warrant. The holder of a whole warrant will be entitled to acquire one share within two years after completion of the offering. Research Capital and Kinsdale Capital Markets have been appointed as agents of the transaction. SQI develops automated diagnostic systems for high-volume, multiple biomarker testing. Targeting the US$1.4bn autoimmune disease market, the company is expecting to launch its first products for rheumatoid arthritis and thrombosis in 2007.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048503

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel